for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

ビジネス

Breakingviews TV: Pill popping

Nov 1 - Pharma giant Amgen is buying a fifth of China biotech star BeiGene for $2.7 bln. A 36% premium seems steep when the target has just shaken off a short-seller attack. But it’s a chance to crack a growing market for cancer drugs, Katrina Hamlin tells Pete Sweeney.

最新のビデオ
エンタテインメント
世界のこぼれ話
スポーツ
テクノロジー

ビジネス

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up